Brief: Sprint Bioscience CEO Erik Kinnman Resigns
Nov 21 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* CEO ERIK KINNMAN RESIGNS
* BOARD INITIATES SEARCH FOR NEW CEO
* ERIK KINNMAN TO REMAIN IN POSITION DURING TRANSITION PERIOD OF ABOUT SIX MONTHS
Source text for Eikon: ID:nMFN4KR69q
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program